Search
-
News
Along with Valentine's Day, February marks American Heart Month. MSK’s Vice Chair of Radiation Oncology, Dr Oren Cahlon talks on how his team are making radiation-induced heart disease “a thing of the past” for our breast cancer patients.
… Tuesday, February 13, 2018
-
News
All radiotherapy treatments for prostate cancer should be accompanied by image-guidance of the prostate position to rule out significant setup errors in fractional delivery.
… Monday, November 19, 2018 All radiotherapy treatments for prostate cancer should be accompanied by image-guidance of the prostate position to rule out significant setup errors in fractional delivery. The results of our most recent analysis of planning data for 102 patients treated consecutively at Memorial
-
News
A leader in developing better treatments for a range of blood cancers, Dr. Omar Abdel-Wahab is only the second person from MSK to receive the Paul Marks Prize for Cancer Research.
… Monday, December 1, 2025 For more than two decades, physician-scientist Omar Abdel-Wahab, MD , has been known around Memorial Sloan Kettering Cancer Center (MSK) for his insight, knowledge, and creativity as a cancer researcher. Now he will also be known as a Paul Marks Prize winner , the first recipient
-
News
Andy Minn, MD, PhD, will return to Memorial Sloan Kettering Cancer Center (MSK) as the inaugural Chair of MSK’s new Immuno-Oncology Program in August.
… Thursday, May 15, 2025 Andy Minn, MD, PhD, will return to Memorial Sloan Kettering Cancer Center (MSK) as the inaugural Chair of MSK’s new Immuno-Oncology Program in August. This is a full-circle moment for Dr. Minn, a renowned physician-scientist, who completed his postdoctoral training with Joan Massagué
-
News
Several MSK physicians and researchers presenting during the plenary sessions.
… Thursday, April 8, 2021 Thousands of oncology experts from around the world will tune in April 10-15 for the American Association for Cancer Research’s (AACR) Annual Meeting: Week 1 . The meeting is the first of two virtual meetings, with clinical trial plenary sessions, clinical trial poster sessions
-
News
A surprising discovery linking the hormone insulin to skin pigmentation offers fresh insights into how animal bodies take shape.
… Thursday, May 24, 2018 Summary Scientists at the Sloan Kettering Institute have made a surprising find about how the hormone insulin contributes to skin pigmentation in fish. The discovery may have implications for human cancer. If you’re a zebra, you want your stripes in order. Come to the savannah
-
News
Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.
… Thursday, September 4, 2014 Summary Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response. An international team of researchers led by Memorial
-
News
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
… Tuesday, January 18, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Francesca M. Gany Named a 2022 Grant Recipient by Prevent Cancer Foundation Francesca M. Gany Francesca M. Gany, MD, MS , Chief, Immigrant Health and Cancer Disparities Service, was
-
Cycle for Survival Kicks Off 2023 Events Nationwide with New Performance Apparel Sponsor Vuori
Along with founding partner Equinox, Cycle for Survival begins its signature team stationary-cycling events this week in New York City. 100% of funds raised go directly to rare cancer research at Memorial Sloan Kettering Cancer Center (MSK).
… Tuesday, March 7, 2023 Cycle for Survival, the movement to beat rare cancers, is launching its annual team stationary-cycling events in 15 locations across the country this weekend in New York City. More than 20,000 riders are expected to participate in person and virtually this March, April, and May
-
News
If you've been treated for soft tissue sarcoma, a recurrence may be a big concern for you. Here's what MSK's sarcoma experts think you should know about the disease coming back.
… Tuesday, July 17, 2018 Summary Memorial Sloan Kettering experts share information and tips for people who are worried about soft tissue sarcoma coming back. Fear of the cancer coming back is common among people who’ve recently been treated for soft tissue sarcoma. Most recurrences tend to happen within